Antimicrobial Use and Antimicrobial Resistance: A Population Perspective

Marc Lipsitch, Matthew H. Samore

Disclosures

Emerging Infectious Diseases. 2002;8(4) 

In This Article

Conclusion

The relationship between antibiotic usage and antibiotic resistance for many types of pathogens is largely mediated by indirect effects or population-level selection. When resistant and susceptible organisms compete to colonize or infect hosts, and use of an antibiotic has a greater impact on the transmission of susceptible bacteria than resistant ones, then increasing use of the antibiotic will result in an increase in frequency of organisms resistant to that drug in the population, even if the risk for treated patients is modest. Antimicrobial use and patient-to-patient transmission are not independent pathways for promoting of antimicrobial resistance, rather they are inextricably linked.

Study designs to assess the effect of antimicrobial use on resistance should reflect these diverse pathways of direct and indirect effects. Estimates of direct effects of antimicrobial use on treated patients will be most informative if clinical cultures are combined with measurements of colonization. Use of time-to-event (e.g., Cox proportional hazards) models provides a natural way of controlling for the patient’s length of stay when assessing the effect of treatment on acquisition of resistant organisms. Analyses that control for a person's exposure to other patients carrying resistant organisms will help to capture the effect modification because of varying transmission pressures during a study. Inclusion of data on antimicrobial use by the group to which others are exposed (siblings, fellow patients on a hospital unit, total use in a community) and to individual-level data will provide one method of estimating both direct and indirect effects of antibiotic use. Nonindependence of individual outcomes makes the interpretation of intervention studies problematic unless measures are taken to account for this nonindependence; cluster-randomized studies, used in other areas of infectious disease epidemiology, are an excellent solution to this problem. We have commented elsewhere on other aspects of study design for antimicrobial resistance, notably the importance of control group selection [7,61,62].

Understanding in detail, for each pathogen, the mechanisms by which antimicrobial use selects for antimicrobial resistance in treated patients and in the population is of more than academic importance. For practitioners, these mechanisms matter for making well-informed decisions about the design of treatment protocols, the choice of antibiotics and doses for particular indications. For policymakers, these issues have direct bearing on the design of campaigns to encourage more rational antibiotic use and on the priorities in regulating the use of antimicrobial agents for human and animal use [63,64].

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....